Management/Leadership
The ICON Development Solutions Leadership includes:
Thomas Frey, MD, MFPM President, ICON Development Solutions Melton Affrime, Pharm.D. Senior Vice President, Global Clinical Pharmacology George Atiee, M.D. Associate Medical Director Ralf Brueckner, M.D. Vice President, Clinical Research and Development Lincoln Bynum, M.D. Vice President, Clinical Research and Development Cyril Clarke, BSc, MB BD, MFPM Medical and Scientific Vice President, Clinical Pharmacology Andrew Copestake, Ph.D. Vice President and General Manager, ICON Development Solutions Marlow Emanuel DeNoia, M.D. Associate Medical Director Michael Fedock, MBA Vice President, Finance Stephanie Jarjabka, MBA, PMP Senior Director, Project Management Laura Johnson, MBA Vice President and General Manager, ICON Development Solutions US Tom Ludden, Ph.D. Vice President, Pharmacometric Research and Development Stuart Madden, Ph.D., FRSC. Senior Vice President Product Development Consulting and Non-Clinical Gracelyn McDermott, MBA, PMP Vice President, Business Development Sandra Nino, Pharm.D., MRA Director, Regulatory Affairs US Brian O'Dwyer, BBS, ACMA Vice President and General Manager, Manchester Clinical Research Unit Dennis Ruff, M.D. Vice President & Medical Director David Shaw, Ph.D. Senior Director, Regulatory Affairs EU
